Inventor · disambiguated record
Joy Yu Zuchero
Also filed as: ZUCHERO JOY YU
11 granted patents·15 pending applications·119 citations·filing 2014–2024
89Inventor score
Top patents by PatentIndex Score
26 records- 0197US9708406B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2014·Granted Jul 18, 2017·87 cites·51 claims
- 0296US11912778B2Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2022·Granted Feb 27, 2024·2 cites·17 claims
- 0396US10143187B2Transferrin receptor transgenic modelsDENALI THERAPEUTICS INC·Filed 2018·Granted Dec 4, 2018·12 cites·34 claims
- 0493US12162948B2Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Granted Dec 10, 2024·1 cites·16 claims
- 0592US10808036B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2017·Granted Oct 20, 2020·5 cites·48 claims
- 0688US11795232B2Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2019·Granted Oct 24, 2023·2 cites·38 claims
- 0788US10508151B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2015·Granted Dec 17, 2019·7 cites·40 claims
- 0888US2024141058A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0987US2024018253A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1085US2025297023A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1183US11008403B2Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of useGENENTECH INC·Filed 2015·Granted May 18, 2021·3 cites·25 claims
- 1282US2024024432A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1382US2024271326A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1476US2023381286A1Affinity-based methods for using transferrin receptor-binding proteinsDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1567US2020369746A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1666US11098129B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2019·Granted Aug 24, 2021·0 cites·34 claims
- 1765US11612150B2Transferrin receptor transgenic modelsDENALI THERAPEUTICS INC·Filed 2018·Granted Mar 28, 2023·0 cites·32 claims
- 1865US2021087288A1Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2020·Application pending·0 cites
- 1964US2020289627A1Affinity-based methods for using transferrin receptor-binding proteinsDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2061US2024299575A1Oligonucleotide conjugates targeted to the transferrin receptorDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2160US2025145729A1Polypeptide engineering, libraries, and engineered cd98 heavy chain and transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2259US2020277584A1Fusion proteins comprising enzyme replacement therapy enzymesDENALI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2352US2022002436A1Anti-her2 polypeptides and methods of use thereofDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2452US2021130485A1Transferrin receptor-binding polypeptides and uses thereofDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2547US11773185B2Anti-BACE1 antibodies and methods of use thereofDENALI THERAPEUTICS INC·Filed 2020·Granted Oct 3, 2023·0 cites·22 claims
- 2640US2018000964A1Blood brain barrier receptor antibodies and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joy Yu Zuchero files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →